Key Highlights
•
A new study found that a simple blood test measuring four specific metabolites can predict which patients with gout are likely to experience painful flares despite taking the standard preventive medication, colchicine. This means doctors could potentially use this test to personalize treatment plans, choosing stronger or longer-lasting flare prevention for high-risk patients right from the start.
Source →
•
For patients with advanced lung cancer driven by an EGFR mutation who also have specific additional genetic flaws (tumor suppressor gene mutations), adding standard chemotherapy to a targeted drug significantly delayed cancer progression compared to the targeted drug alone. This finding offers a new, more effective treatment strategy for a subset of patients who typically have worse outcomes.
Source →
•
A large review of children with Valley Fever (coccidioidomycosis) found that doctors manage the infection very differently, with some using long courses of antifungal drugs and others simply monitoring without medication. Importantly, the study showed that simply observing patients without immediate treatment rarely failed, and relapses after stopping medication were uncommon, suggesting a more conservative approach may be safe for many children.
Source →
•
A new oral form of the common chemotherapy drug paclitaxel was found to be as effective as the traditional intravenous version for treating certain advanced breast cancers. If approved, this pill could offer patients a more convenient treatment option, eliminating the need for lengthy clinic visits for IV infusions and reducing risks like severe allergic reactions.
Source →
•
A specialized form of talk therapy (exposure-based cognitive behavioral therapy) delivered by intensive community mental health teams significantly reduced anxiety and improved quality of life for people with severe mental illnesses like schizophrenia. This shows that effective psychological treatments can be successfully integrated into real-world, community-based care for some of the most vulnerable patients.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
